LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Chinook Therapeutics, a Novartis Company and Millions of Other Companies

Sign up for full access to Chinook Therapeutics, a Novartis Company information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Strategic Partnerships Chinook Therapeutics has engaged in strategic partnerships with well-known companies like Novartis, Ionis Pharmaceuticals, and AbbVie. Leveraging these collaborations can open doors for cross-selling opportunities and access to a broader customer base.

Pipeline Expansion With the launch of pivotal phase 3 BEYOND study of zigakibart for IgA nephropathy patients, Chinook Therapeutics is expanding its product portfolio. Leveraging this new offering can provide avenues for upselling to existing clients and attracting new customers.

Financial Stability Chinook Therapeutics boasts a revenue range of $10-50 million and has secured funding of $345 million. Their strong financial position indicates potential investment opportunities for clients interested in partnering with stable and well-funded companies.

Acquisition by Novartis Being acquired by Novartis has transformed Chinook Therapeutics into a subsidiary, providing them with the backing of a global pharmaceutical giant. Utilizing Novartis's extensive network and resources can create avenues for expanded sales reach and market penetration.

Addressing Unmet Medical Needs Through collaboration with Ionis Pharmaceuticals for developing ASO therapy for rare kidney diseases, Chinook Therapeutics is targeting unmet medical needs. Positioning this innovative therapy as a unique selling point can attract clients looking to support groundbreaking medical solutions.

Similar companies to Chinook Therapeutics, a Novartis Company

✕

Access Insights for Chinook Therapeutics, a Novartis Company and Millions of Other Companies

Sign up for full access to Chinook Therapeutics, a Novartis Company information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Chinook Therapeutics, a Novartis Company Tech Stack

Chinook Therapeutics, a Novartis Company uses 8 technology products and services including SciPy, Google Hosted Libraries, UltiPro, and more. Explore Chinook Therapeutics, a Novartis Company's tech stack below.

  • SciPy
    Advanced Analytics And Data Science
  • Google Hosted Libraries
    Content Delivery Network
  • UltiPro
    Human Resource Management System
  • Windows Server
    Operating Systems
  • Linux
    Programming Languages
  • Smartsheet
    Project Management
  • VMware
    Virtualisation Software
  • Apache HTTP Server
    Web Servers

Media & News

Chinook Therapeutics, a Novartis Company's Email Address Formats

Chinook Therapeutics, a Novartis Company uses at least 1 format(s):
Chinook Therapeutics, a Novartis Company Email FormatsExamplePercentage
FLast@chinooktx.comJDoe@chinooktx.com
99%
FMiddleLast@chinooktx.comJMichaelDoe@chinooktx.com
1%

Frequently Asked Questions

Where is Chinook Therapeutics, a Novartis Company's headquarters located?

Minus sign iconPlus sign iconChinook Therapeutics, a Novartis Company's main headquarters is located at Seattle, WA 98102 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Chinook Therapeutics, a Novartis Company's official website and social media links?

Minus sign iconPlus sign iconChinook Therapeutics, a Novartis Company's official website is chinooktx.com and has social profiles on LinkedIn.

How much revenue does Chinook Therapeutics, a Novartis Company generate?

Minus sign iconPlus sign icon As of August 2024, Chinook Therapeutics, a Novartis Company's annual revenue reached $35M.

What is Chinook Therapeutics, a Novartis Company's SIC code NAICS code?

Minus sign iconPlus sign iconChinook Therapeutics, a Novartis Company's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Chinook Therapeutics, a Novartis Company have currently?

Minus sign iconPlus sign iconAs of August 2024, Chinook Therapeutics, a Novartis Company has approximately 201 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Commercial Officer: A. O.Chief Medical Officer: A. G.Vice President Legal: N. N.. Explore Chinook Therapeutics, a Novartis Company's employee directory with LeadIQ.

What industry does Chinook Therapeutics, a Novartis Company belong to?

Minus sign iconPlus sign iconChinook Therapeutics, a Novartis Company operates in the Biotechnology Research industry.

What technology does Chinook Therapeutics, a Novartis Company use?

Minus sign iconPlus sign iconChinook Therapeutics, a Novartis Company's tech stack includes SciPyGoogle Hosted LibrariesUltiProWindows ServerLinuxSmartsheetVMwareApache HTTP Server.

What is Chinook Therapeutics, a Novartis Company's email format?

Minus sign iconPlus sign iconChinook Therapeutics, a Novartis Company's email format typically follows the pattern of . Find more Chinook Therapeutics, a Novartis Company email formats with LeadIQ.

How much funding has Chinook Therapeutics, a Novartis Company raised to date?

Minus sign iconPlus sign icon As of August 2024, Chinook Therapeutics, a Novartis Company has raised $345M in funding. The last funding round occurred on Aug 22, 2019 for $65M.

When was Chinook Therapeutics, a Novartis Company founded?

Minus sign iconPlus sign iconChinook Therapeutics, a Novartis Company was founded in 2019.
Chinook Therapeutics, a Novartis Company

Chinook Therapeutics, a Novartis Company

Biotechnology ResearchWashington, United States201-500 Employees

Chinook Therapeutics is now a Novartis Company! On August 11, 2023, Novartis completed its acquisition of Chinook. Follow the Novartis channel or visit www.novartis.com to stay updated on atrasentan, zigakibart and the rest of the Chinook pipeline. 

For more information on the acquisition, see our press release at: https://www.novartis.com/news/media-releases/novartis-completes-acquisition-chinook-therapeutics

See our community guidelines: https://go.novartis.social/3Slt0Up

✕

Access Insights for Chinook Therapeutics, a Novartis Company and Millions of Other Companies

Sign up for full access to Chinook Therapeutics, a Novartis Company information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
Seattle, WA 98102 US
Website
chinooktx.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $345M

    Chinook Therapeutics, a Novartis Company has raised a total of $345M of funding over 2 rounds. Their latest funding round was raised on Aug 22, 2019 in the amount of $65Mas a Series A.

  • $10M$50M

    Chinook Therapeutics, a Novartis Company's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $345M

    Chinook Therapeutics, a Novartis Company has raised a total of $345M of funding over 2 rounds. Their latest funding round was raised on Aug 22, 2019 in the amount of $65Mas a Series A.

  • $10M$50M

    Chinook Therapeutics, a Novartis Company's revenue is in the range of $10M$50M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Chinook Therapeutics, a Novartis Company and Millions of Other Companies

Sign up for full access to Chinook Therapeutics, a Novartis Company information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.